Tianjin Pharmaceutical Da Ren Tang to Provide 832.7 Million Yuan Guarantee for Subsidiary

MT Newswires09-12

Tianjin Pharmaceutical Da Ren Tang (SGX:T14, SHA:600329) plans to provide an 832.7 million yuan guarantee for its subsidiary Tianjin Zhongxin Medicine, according to a Wednesday filing on the Singapore Exchange.

The guarantee is part of a broader plan to support Tianjin Zhongxin's ongoing operations and facilitate the restructuring of its entrusted loans.

The guarantee will be provided as part of a joint and several liability agreement with Tianjin Pharmaceutical Holding, another shareholder in Tianjin Zhongxin.

It corresponds to Tianjin Pharmaceutical Da Ren Tang's 43.35% stake in Tianjin Pharmaceutical Group Taiping Medicine.

The guarantee requires shareholder approval at an upcoming extraordinary general meeting.

Price (SGD): S$2.05, Change: S$+0.020, Percent Change: +0.99%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2466934290?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-12 10:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466934290","market":"sg","top_or_hot":-1,"title":"Tianjin Pharmaceutical Da Ren Tang to Provide 832.7 Million Yuan Guarantee for Subsidiary","media":"MT Newswires","content":"<html><body><p> Tianjin Pharmaceutical Da Ren Tang (SGX:T14, SHA:600329) plans to provide an 832.7 million yuan guarantee for its subsidiary Tianjin Zhongxin Medicine, according to a Wednesday filing on the Singapore Exchange.</p><p>The guarantee is part of a broader plan to support Tianjin Zhongxin's ongoing operations and facilitate the restructuring of its entrusted loans.</p><p>The guarantee will be provided as part of a joint and several liability agreement with Tianjin Pharmaceutical Holding, another shareholder in Tianjin Zhongxin.</p><p>It corresponds to Tianjin Pharmaceutical Da Ren Tang's 43.35% stake in Tianjin Pharmaceutical Group Taiping Medicine.</p><p>The guarantee requires shareholder approval at an upcoming extraordinary general meeting.</p><p>Price (SGD): S$2.05, Change: S$+0.020, Percent Change: +0.99%</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tianjin Pharmaceutical Da Ren Tang to Provide 832.7 Million Yuan Guarantee for Subsidiary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTianjin Pharmaceutical Da Ren Tang to Provide 832.7 Million Yuan Guarantee for Subsidiary\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-12 10:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tianjin Pharmaceutical Da Ren Tang (SGX:T14, SHA:600329) plans to provide an 832.7 million yuan guarantee for its subsidiary Tianjin Zhongxin Medicine, according to a Wednesday filing on the Singapore...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600329","symbol_name":"达仁堂","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2466934290","we_media_id":"1060499803","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466934290","pubTimestamp":1726108584,"sourceInfo":null,"weMediaInfo":{"media_name":"MT Newswires","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1060499803","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Tianjin Pharmaceutical Da Ren Tang  plans to provide an 832.7 million yuan guarantee for its subsidiary Tianjin Zhongxin Medicine, according to a Wednesday filing on the Singapore Exchange.The guarantee is part of a broader plan to support Tianjin Zhongxin's ongoing operations and facilitate the restructuring of its entrusted loans.The guarantee will be provided as part of a joint and several liability agreement with Tianjin Pharmaceutical Holding, another shareholder in Tianjin Zhongxin.It corresponds to Tianjin Pharmaceutical Da Ren Tang's 43.35% stake in Tianjin Pharmaceutical Group Taiping Medicine.The guarantee requires shareholder approval at an upcoming extraordinary general meeting.Price : S$2.05, Change: S$+0.020, Percent Change: +0.99%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600329":"达仁堂","BK0164":"国企混改","BK6079":"制药","T14.SI":"达仁堂","BK0188":"融资融券","BK6506":"制药与医学研究概念","BK0028":"国家队","BK0060":"抗癌","BK0239":"医药制造"},"translate_title":"天津医药大仁堂将为子公司提供8.327亿元担保","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600329":0.9,"T14.SI":0.9},"content_text":"Tianjin Pharmaceutical Da Ren Tang (SGX:T14, SHA:600329) plans to provide an 832.7 million yuan guarantee for its subsidiary Tianjin Zhongxin Medicine, according to a Wednesday filing on the Singapore Exchange.The guarantee is part of a broader plan to support Tianjin Zhongxin's ongoing operations and facilitate the restructuring of its entrusted loans.The guarantee will be provided as part of a joint and several liability agreement with Tianjin Pharmaceutical Holding, another shareholder in Tianjin Zhongxin.It corresponds to Tianjin Pharmaceutical Da Ren Tang's 43.35% stake in Tianjin Pharmaceutical Group Taiping Medicine.The guarantee requires shareholder approval at an upcoming extraordinary general meeting.Price (SGD): S$2.05, Change: S$+0.020, Percent Change: +0.99%","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2466934290"}